Industry News 21 Oct 2026

Okomera Announces a Commercial Agreement With Servier to Use Its Tumor Miniaturization Technology for Cancer Research

Source: Businesswire •1 min read

PARIS--(BUSINESS WIRE)-- #Okomera--Okomera, a TechBio company pioneering personalized cancer care through a proprietary technology platform combining tumor mini-avatars, microfluidics, and AI-powered imaging, today announced the signing of a commercial agreement with Servier, an independent international pharmaceutical group, to use its technology in the development of new cancer treatments. With more than 90% of oncology drug candidates never reaching the market, identifying early on the therapeutic appr

This is a short summary. The full story is published by Businesswire.

Read full story at Businesswire

Related news

Amgen (AMGN): The Biotech Pioneer Preparing for Its Next Growth Wave

Initially, the pharmaceutical industry was built on the ability to identify, isolate, and purify chemical compounds with medicinal virtues, for…

Securities Io• 19 Oct 2026 •1 min read
Torrent Pharma Profit Falls 9.6 Per Cent, Dr Reddy’s Slumps 36 Pc In Q2 FY27

Torrent Pharmaceuticals’ Q2 FY27 net profit fell 9.6% to Rs 534 crore, although revenue rose 50.8% to Rs 4,979 crore as expenses climbed 70.9%. Dr…

The Free Press Journal• 23 Oct 2026 •1 min read
Palleon Pharmaceuticals Presents Phase 2 Results for HLX79/E-602 in Primary Membranous Nephropathy at ASN Kidney Week…

Palleon Pharmaceuticals, a clinical-stage biotechnology company developing glycan editing therapeutics for autoimmune disease and cancer, today…

Financialcontent• 23 Oct 2026 •1 min read
Lupin appoints Brian Savage as President, Chief Legal Officer

He joins Lupin from Teva Pharmaceuticals, where he held several senior leadership roles since 2015, serving most recently as executive vice…

The Hindu - Business Line• 23 Oct 2026 •1 min read
Limited-Time Offer
Advertise on PharmaJungle - Free for 30 Days

Get your company in front of buyers, manufacturers, and sourcing professionals on PharmaJungle - completely free for your first 30 days.

  • 30 days of free advertising
  • Visibility across all pages
  • Performance report with ad insights
  • No setup or registration fee
Claim Your Free Ad

Exclusive introductory offer for new advertisers

Top sources
A Abnewswire 10 stories
I Indianpharmapost 5 stories
F Finanznachrichten.de 5 stories
K Kalkine Media 4 stories
F FDA 4 stories
PharmaJungle
Buying request

Post your requirement

Get offers from suppliers

  • Reach pharmaceutical suppliers
  • Specify quality standard and quantity
  • Set your shipping preference
  • Receive offers directly
  • Listed on our marketplace

Your product details and requirements may be published on the marketplace.

PharmaJungle

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.